InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,178.00
(
1.88%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.76
(
0.15%
)
Bitcoin
59,537.79
(
0.70%
)

Replies to post #944 on Harvard Apparatus Regenerative Tech Inc. (HRGN)

Replies to #944 on Harvard Apparatus Regenerative Tech Inc. (HRGN)

hondobud

03/29/17 3:43 PM

#945 RE: UP Trend #944

Biostage to Participate at the MassBio 2017 Annual Meeting
Tuesday 03/28/2017 07:05 AM ET - PR Newswire via Dow Jones News

Biostage to present in the 3D Printing and BioEngineering panel on Thursday, March 30 at 2:30 PM ET HOLLISTON, Mass., March 28, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, today announced that Jim McGorry, CEO of Biostage, will present on the 3D Printing and BioEngineering panel at the MassBio 2017 Annual Meeting on Thursday, March 30, 2017 at 2:30 PM ET in Cambrige, Massachussetts. The 3D Printing and BioEngineering panel will address the developments and discoveries in 3D printing in medicine and research, focusing on how advances in 3D printing are pushing the boundaries of medical innovation.